Article featured in WholeFoods magazine
Sabinsa announced that Curcumin C3 Reduct has been approved by the National Health Surveillance Agency in Brazil for
inclusion on ANVISA’s IN28 list.
Sabinsa Gains First Approval for ANVISA’s IN28 in Brazil for C3 Reduct®
Article featured in Nutraceutical Business Review
This approval allows introduction and commercialization of C3 Reduct, most active metabolite of curcumin, in food and
supplements in Brazil.
Article featured in Nutra Ingredients USA
Natural ingredient supplier Sabinsa announced this week that The Brazilian Health Regulatory Agency (ANVISA) has
green-lighted its Curcumin C3 Reduct as health ingredient in the country.
Article featured in Nutrition Insight
This week in nutrition news, Sabinsa gained authorization from Brazil’s National Health Surveillance Agency (ANVISA) for
Curcumin C3 Reduct to enter the country’s market.
Article featured in Nutritional Outlook
Curcumin C3 Reduct has earned approval by the National Health Surveillance Agency in Brazil for inclusion on ANVISA’s
IN28 list, which allows the product to be introduced and commercialized in food and supplements in Brazil.
